KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Gains from Investment Securities (2016 - 2026)

Chemed filings provide 18 years of Gains from Investment Securities readings, the most recent being $1.5 million for Q1 2026.

  • For the quarter ending Q1 2026, Gains from Investment Securities rose 427.4% year-over-year to $1.5 million, compared with a TTM value of $2.1 million through Mar 2026, up 140.57%, and an annual FY2025 reading of $888000.0, up 201.02% over the prior year.
  • Gains from Investment Securities hit $1.5 million in Q1 2026 for Chemed, up from -$7.6 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $12.4 million in Q3 2022, with the low at -$11.6 million in Q4 2022.
  • Median Gains from Investment Securities over the past 5 years was $881500.0 (2025), compared with a mean of $818750.0.
  • The sharpest move saw Gains from Investment Securities crashed 1657.51% in 2022, then surged 6337.59% in 2024.
  • Year by year, Gains from Investment Securities stood at -$11.6 million in 2022, then surged by 135.38% to $4.1 million in 2023, then plummeted by 307.54% to -$8.5 million in 2024, then rose by 10.97% to -$7.6 million in 2025, then surged by 119.51% to $1.5 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $1.5 million, -$7.6 million, and $8.2 million for Q1 2026, Q4 2025, and Q2 2025 respectively.